Skip to main content
. Author manuscript; available in PMC: 2012 Jan 24.
Published in final edited form as: Stroke. 2011 Sep 22;42(12):3551–3558. doi: 10.1161/STROKEAHA.111.627174

Figure 5.

Figure 5

T1DM-MCAO rats increases angiogenin expression and BMSC treatment in T1DM-MCAO rats significantly enhances angiogenin and ED1 expression. A–B, Angiogenin immunostaining and quantitative data in IBZ (A) and in the ICA (B). C, ED1 immunostaining and quantitative data in ICA. Scale bar in A–C=0.1 mm. T1DM indicates Type 1 diabetes mellitus; MCAO, middle cerebral artery occlusion; BMSC, bone marrow stromal cell; IBZ, ischemic border zone; ICA, internal carotid artery.